Spots Global Cancer Trial Database for lung cancer stage iv
Every month we try and update this database with for lung cancer stage iv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating | NCT03322072 | Lung Cancer Sta... Lung Cancer Sta... Lung Cancer, No... Lung Cancer Rec... Lung Cancer Sta... | Real-Time Posit... | 18 Years - 85 Years | CancerCare Manitoba | |
| Personalizing Immune Checkpoint Inhibitor Therapy | NCT03409341 | Lung Cancer Sta... | Blood and tumor... | 18 Years - 70 Years | Holy Cross Hospital, Maryland | |
| Self-System Therapy for Older Adults With Lung Cancer | NCT04057196 | Lung Cancer Sta... Lung Cancer Sta... | Self-System The... | 65 Years - 100 Years | Duke University | |
| Study of RAS(ON) Inhibitor Combinations in Patients With Advanced RAS-mutated NSCLC | NCT06162221 | Non-Small Cell ... KRAS, NRAS, HRA... KRAS G12C-mutat... Lung Cancer Sta... | RMC-6291 RMC-6236 Pembrolizumab Cisplatin Carboplatin Pemetrexed | 18 Years - | Revolution Medicines, Inc. | |
| Study of RAS(ON) Inhibitor Combinations in Patients With Advanced RAS-mutated NSCLC | NCT06162221 | Non-Small Cell ... KRAS, NRAS, HRA... KRAS G12C-mutat... Lung Cancer Sta... | RMC-6291 RMC-6236 Pembrolizumab Cisplatin Carboplatin Pemetrexed | 18 Years - | Revolution Medicines, Inc. | |
| A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib | NCT03076164 | Lung Adenocarci... Lung Cancer Lung Cancer Met... Lung Cancer Sta... Recurrent Lung ... Recurrent Lung ... | Trametinib Erlotinib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer | NCT03728361 | Grade I Neuroen... Grade II Neuroe... Grade III Neuro... Metastatic Neur... Neuroendocrine ... Recurrent Small... Refractory Smal... Lung Cancer Sta... Large Cell Neur... Neuroendocrine ... Small Cell Lung... Small-cell Lung... | Nivolumab Temozolomide | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers | NCT05860296 | Lung Cancer, No... Lung Cancer Sta... Lung Cancer Met... | SLC-391 pembrolizumab | 18 Years - | SignalChem Lifesciences Corporation | |
| Lazertinib 160mg in EGFR T790M NSCLC | NCT05701384 | Lung Cancer Sta... EGFR T790M | Lazertinib | 19 Years - | Samsung Medical Center | |
| The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer | NCT06000358 | Lung Cancer Sta... | Bronchoscopic c... Pembrolizumab Platinum based ... | 18 Years - 99 Years | Lithuanian University of Health Sciences | |
| Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating | NCT03322072 | Lung Cancer Sta... Lung Cancer Sta... Lung Cancer, No... Lung Cancer Rec... Lung Cancer Sta... | Real-Time Posit... | 18 Years - 85 Years | CancerCare Manitoba | |
| Resilience Measurement in Older Adults With Late-Stage Lung Cancer | NCT04825912 | Lung Cancer Sta... Lung Cancer Sta... | Self System The... | 65 Years - 100 Years | Duke University | |
| Psychosocial eHealth in Advanced Lung Cancer | NCT05497973 | Lung Cancer, No... Lung Cancer Non... Lung Cancer Non... Lung Cancer Sta... Lung Cancer | E-health ecosys... Usual psychosoc... | 18 Years - 80 Years | Institut Català d'Oncologia | |
| Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers | NCT05860296 | Lung Cancer, No... Lung Cancer Sta... Lung Cancer Met... | SLC-391 pembrolizumab | 18 Years - | SignalChem Lifesciences Corporation | |
| Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patients | NCT03529851 | Lung Cancer Sta... | Weekly question... | 18 Years - | Regional Hospital West Jutland | |
| Lung Cancer ID (Identity) Study | NCT06076005 | Lung Cancer Sta... | Advanced lung c... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib | NCT03076164 | Lung Adenocarci... Lung Cancer Lung Cancer Met... Lung Cancer Sta... Recurrent Lung ... Recurrent Lung ... | Trametinib Erlotinib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay | NCT03558165 | Lung Cancer Sta... | Oncomine Compre... | 18 Years - | University Health Network, Toronto | |
| Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion | NCT04669223 | Pleural Effusio... Lung Cancer Sta... Chest Tubes | Seldinger chest... | 18 Years - | The University of Hong Kong | |
| Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patients | NCT03529851 | Lung Cancer Sta... | Weekly question... | 18 Years - | Regional Hospital West Jutland | |
| Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs | NCT04519983 | Lung Cancer Sta... | Aumolertinib Or... | 15 Years - 75 Years | Shanghai Cancer Hospital, China | |
| Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities | NCT05311709 | Lung Cancer NSCLC, Stage II... NSCLC Stage IV Lung Cancer Sta... Mutation Cancer Cancer, Lung | sotorasib | 18 Years - | Vestre Viken Hospital Trust | |
| Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs | NCT04519983 | Lung Cancer Sta... | Aumolertinib Or... | 15 Years - 75 Years | Shanghai Cancer Hospital, China | |
| Self-System Therapy for Older Adults With Lung Cancer | NCT04057196 | Lung Cancer Sta... Lung Cancer Sta... | Self-System The... | 65 Years - 100 Years | Duke University | |
| Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer | NCT06024941 | Lung Cancer Sta... | Radiation | 18 Years - | Maastricht Radiation Oncology | |
| The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer | NCT06000358 | Lung Cancer Sta... | Bronchoscopic c... Pembrolizumab Platinum based ... | 18 Years - 99 Years | Lithuanian University of Health Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
